Usman Baber to Rivaroxaban
This is a "connection" page, showing publications Usman Baber has written about Rivaroxaban.
Connection Strength
0.250
-
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study. Am Heart J. 2017 Feb; 184:81-87.
Score: 0.134
-
Balancing ischaemia and bleeding risks with novel oral anticoagulants. Nat Rev Cardiol. 2014 Dec; 11(12):693-703.
Score: 0.117